Coherus BioSciences Inc.

NASDAQ: CHRS · Real-Time Price · USD
1.04
0.02 (1.96%)
At close: Aug 15, 2025, 3:59 PM
1.02
-2.39%
After-hours: Aug 15, 2025, 07:33 PM EDT

Coherus BioSciences Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
142.77M 197.5M 192.21M 229.59M 233.38M 227.12M 257.24M 211.07M 181.93M 183.36M 211.04M 239.06M 276.14M 303.63M 326.55M 363.6M 394.65M 442.68M
Cost of Revenue
61.66M 86.81M 120.25M 172.02M 183.98M 179.27M 160.06M 88.63M 91.16M 77.59M 70.08M 67.98M 54.03M 59.45M 57.59M 57.16M 44.88M 38.32M
Gross Profit
81.11M 110.69M 146.71M 132.32M 124.15M 122.6M 97.19M 122.44M 90.77M 105.78M 140.96M 171.08M 222.11M 244.18M 268.96M 306.44M 349.77M 404.36M
Operating Income
-139.55M -114.58M -111.67M -137.78M -163.4M -177.43M -202.65M -185.79M -234.23M -243.7M -256.88M -244.93M -197.27M -177.42M -263.86M -207.89M -141.38M -51.91M
Interest Income
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Pretax Income
-153.71M -121.77M 28.51M -450K -29.72M -59.67M -238.27M -217.49M -264.12M -271.4M -291.75M -278.61M -230.49M -210.24M -287.1M -230.62M -163.97M -73.75M
Net Income
179.75M -130.94M 28.51M -450K -29.34M -59.29M -236.94M -223.54M -276.75M -290.17M -326.63M -306.11M -251.78M -225.4M -287.1M -231.67M -165.21M -76.28M
Selling & General & Admin
128.1M 137.23M 160.94M 168.59M 182.07M 192.05M 191.47M 196.14M 192.75M 198.88M 198.48M 194.91M 190.01M 179.07M 169.71M 157.35M 149.41M 143.12M
Research & Development
93.57M 88.03M 90.64M 94.71M 98.68M 101.18M 108.37M 112.09M 132.25M 150.59M 199.36M 221.1M 229.38M 242.53M 363.11M 356.97M 341.74M 313.14M
Other Expenses
-1.02M n/a n/a n/a n/a n/a n/a n/a n/a 443K 475K 90K 120K -312K -283K 108K 134K 546K
Operating Expenses
220.66M 225.27M 251.58M 263.3M 280.75M 293.23M 299.84M 308.23M 325M 349.48M 397.84M 416.01M 419.38M 421.61M 532.82M 514.33M 491.15M 456.26M
Interest Expense
15.13M 18.19M 27.16M 32.43M 37.34M 41.95M 40.54M 39.31M 36.58M 33.22M 32.47M 28.88M 27.11M 26.28M 22.96M 22.84M 22.72M 22.38M
Selling & Marketing Expenses
10.9M 10.9M 10.9M 10.9M 10.9M 10.9M 10.9M 10.5M 10.5M 10.5M 10.5M 8.7M 8.7M 8.7M 8.7M 3.8M 3.8M 3.8M
Cost & Expenses
282.32M 312.07M 329.13M 392.63M 422.04M 429.81M 459.9M 396.86M 416.16M 427.06M 467.92M 484M 473.41M 481.06M 590.41M 571.49M 536.03M 494.59M
Income Tax Expense
-342.63M n/a n/a n/a -380K -380K -1.33M 6.05M 12.63M 18.77M 34.87M 27.5M 21.3M 15.16M n/a 1.05M 1.24M 2.53M
Shares Outstanding (Basic)
116.08M 115.86M 115.42M 115.21M 114.82M 112.75M 111.49M 97.74M 87.27M 79.27M 77.96M 77.75M 77.15M 77.25M 76.35M 78.63M 75.56M 72.83M
Shares Outstanding (Diluted)
116.08M 115.86M 115.42M 115.21M 114.82M 125.53M 111.49M 97.74M 87.27M 79.27M 77.96M 77.75M 77.55M 77.25M 76.83M 79.01M 75.56M 72.83M
EPS (Basic)
-1.38 -1.13 0.27 -0.00 -0.32 -0.7 -2.55 -2.69 -3.47 -3.71 -4.21 -3.96 -3.26 -2.93 -3.86 -3.13 -2.25 -1.02
EPS (Diluted)
-1.38 -1.13 0.18 -0.09 -0.41 -0.79 -2.55 -2.69 -3.47 -3.71 -4.21 -3.96 -3.26 -2.93 -3.86 -3.14 -2.32 -1.22
EBITDA
-137.84M -98.76M 60.94M 37.29M 13.01M -12.63M -193.2M -173.66M -223.76M -234.38M -255.66M -245.74M -198.83M -179.44M -259.01M -203.24M -137.53M -48.19M
EBIT
-138.57M -103.57M 55.66M 31.98M 7.62M -17.72M -197.73M -178.18M -227.54M -238.18M -259.28M -249.73M -203.37M -183.96M -264.14M -207.78M -141.25M -51.36M
Depreciation & Amortization
4.64M 4.82M 5.28M 5.31M 5.39M 5.09M 4.53M 4.52M 3.78M 3.8M 3.62M 3.99M 4.54M 5.08M 5.69M 5.11M 4.35M 3.66M